UTMD EBITDA Margin
Utah Medical Products Inc · EBITDA Margin
UTMD EBITDA Margin
Latest reported40.75%period ending
UTMD TTM EBITDA Margin (9.21% → 40.75%)
TTM ebitda margin
High-resolution chart · PNG
UTMD ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 40.7456% | |
| 43.7185% | |
| 43.4227% | |
| 43.6337% | |
| 45.5829% | |
| 45.8534% | |
| 46.7863% | |
| 47.1528% | |
| 48.1579% | |
| 49.9103% | |
| 51.3161% | |
| 53.6695% | |
| 54.2021% | |
| 53.6673% | |
| 53.3474% | |
| 52.931% | |
| 53.1374% | |
| 53.3989% | |
| 53.647% | |
| 52.92% | |
| 51.8575% | |
| 49.6544% | |
| 49.5898% | |
| 50.7988% | |
| 50.2272% | |
| 52.3549% | |
| 52.2973% | |
| 51.3161% | |
| 51.402% | |
| 51.318% | |
| 51.5572% | |
| 51.8036% | |
| 52.736% | |
| 52.6973% | |
| 52.6706% | |
| 52.008% | |
| 50.7387% | |
| 49.4701% | |
| 48.5368% | |
| 48.3811% | |
| 48.4573% | |
| 47.826% | |
| 46.9084% | |
| 47.0748% | |
| 46.3308% | |
| 46.6078% | |
| 47.1365% | |
| 45.9922% | |
| 45.792% | |
| 45.3287% | |
| 44.7213% | |
| 44.7777% | |
| 45.0514% | |
| 44.7042% | |
| 44.4132% | |
| 43.002% | |
| 41.7571% | |
| 40.7447% | |
| 38.859% | |
| 39.1447% | |
| 38.5463% | |
| 37.894% | |
| 38.5041% | |
| 39.0474% | |
| 38.8067% | |
| 38.8173% | |
| 39.4289% | |
| 37.8324% | |
| 39.2227% | |
| 39.8566% | |
| 39.5278% | |
| 40.3652% | |
| 39.6763% | |
| 39.6124% | |
| 39.8358% | |
| 39.8596% | |
| 40.1185% | |
| 40.0563% | |
| 39.888% | |
| 38.3928% | |
| 35.9464% | |
| 35.4285% | |
| 35.7973% | |
| 37.1789% | |
| 39.6789% | |
| 40.681% | |
| 41.2233% | |
| 42.1074% | |
| 42.6646% | |
| 43.1389% | |
| 43.1367% | |
| 43.1044% | |
| 43.1545% | |
| 43.0502% | |
| 42.8128% | |
| 51.0142% | |
| 50.7233% | |
| 50.4835% | |
| 50.3487% | |
| 41.6176% |